Abbott India net profit up 1 percent to Rs 181 crore in Q2
New Delhi: Drug maker Abbott India on Wednesday reported a 1.34 percent increase in net profit at Rs 180.73 crore for the second quarter ended September 30. The company had posted a net profit of Rs 178.33 crore in July-September quarter of previous fiscal.Revenue from operations remained flat at Rs 1,054.85 crore during the quarter under review as compared with Rs 1,054.80 crore in the...
Login or Register to read the full article
New Delhi: Drug maker Abbott India on Wednesday reported a 1.34 percent increase in net profit at Rs 180.73 crore for the second quarter ended September 30. The company had posted a net profit of Rs 178.33 crore in July-September quarter of previous fiscal.
Revenue from operations remained flat at Rs 1,054.85 crore during the quarter under review as compared with Rs 1,054.80 crore in the year-ago period, Abbott India said in a regulatory filing.
The extended lockdown on account of Covid-19 has led to a slowdown in demand in some therapeutic areas and resulted in lower sales, it added.
The company continues to closely monitor the situation and will take appropriate measures in an attempt to mitigate any adverse impact, it said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd